Open AccessP639: OUTCOMES FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA PREVIOUSLY TREATED WITH A COVALENT BTK AND BCL2 INHIBITOR IN THE UNITED STATES: A REAL‐WORLD DATABASE STUDY
Author(s) -
Mato A. R.,
Chen Y.,
Girvan A. C.,
Hess L. M.,
Bowman L.,
Abada P.,
Konig H.,
Walgren R. A.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000845440.90671.95
Subject(s) - medicine , venetoclax , regimen , chronic lymphocytic leukemia , clinical trial , ibrutinib , maintenance therapy , oncology , leukemia , chemotherapy